Genetics Generation Advancement Corp. (4160.TWO)

TWD 55.0

(-3.68%)

Operating Expenses Summary of Genetics Generation Advancement Corp.

  • Genetics Generation Advancement Corp.'s latest annual operating expenses in 2023 was 218.25 Million TWD , up 6.5% from previous year.
  • Genetics Generation Advancement Corp.'s latest quarterly operating expenses in 2024 Q2 was 58.31 Million TWD , up 8.58% from previous quarter.
  • Genetics Generation Advancement Corp. reported a annual operating expenses of 205.57 Million TWD in annual operating expenses 2022, up 2.79% from previous year.
  • Genetics Generation Advancement Corp. reported a annual operating expenses of 200 Million TWD in annual operating expenses 2021, up 22.98% from previous year.
  • Genetics Generation Advancement Corp. reported a quarterly operating expenses of 53.7 Million TWD for 2024 Q1, down -6.91% from previous quarter.
  • Genetics Generation Advancement Corp. reported a quarterly operating expenses of 57.68 Million TWD for 2023 Q4, down -3.36% from previous quarter.

Annual Operating Expenses Chart of Genetics Generation Advancement Corp. (2023 - 2019)

Created with Highcharts 11.1.0YearsOperating Expenses20192019.520202020.520212021.520222022.52023140000000 TWD160000000 TWD180000000 TWD200000000 TWD220000000 TWD

Historical Annual Operating Expenses of Genetics Generation Advancement Corp. (2023 - 2019)

Year Operating Expenses Operating Expenses Growth
2023 218.25 Million TWD 6.5%
2022 205.57 Million TWD 2.79%
2021 200 Million TWD 22.98%
2020 162.62 Million TWD 4.02%
2019 156.34 Million TWD 0.0%

Peer Operating Expenses Comparison of Genetics Generation Advancement Corp.

Name Operating Expenses Operating Expenses Difference
BIONET Corp. 553.58 Million TWD 60.574%
DIVA Laboratories, Ltd. 158.62 Million TWD -37.595%
Welgene Biotech Co.,Ltd. 123.97 Million TWD -76.047%
Puriblood Medical Co., Ltd. 56.92 Million TWD -283.4%
TFBS Bioscience Inc. 77.82 Million TWD -180.428%